Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hellyer

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|September 22, 2015
Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illnessJonathan Scott, Graham J Harris, Emma M Pinder, et al.
Thorax|August 2, 2018
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosisEmma M Pinder, Anthony J Rostron, Thomas P Hellyer, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational StudyNeil Powell, Philip Howard, Martin J Llewelyn, et al.
BMJ Open|August 8, 2025
Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sourcesJosie Henley, Lucy Brookes-Howell, Philip Howard, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
Wellcome Open Research|November 16, 2022
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumoniaVilas Navapurkar, Josefin Bartholdson Scott, Mailis Maes, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2024
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19Jonathan A T Sandoe, Detelina Grozeva, Mahableshwar Albur, et al.
Thorax|October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
JAMA|December 9, 2024
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical TrialPaul Dark, Anower Hossain, Daniel F McAuley, et al.
Annals of Translational Medicine|August 15, 2020
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumoniaThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|September 22, 2015
Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illnessJonathan Scott, Graham J Harris, Emma M Pinder, et al.
Thorax|August 2, 2018
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosisEmma M Pinder, Anthony J Rostron, Thomas P Hellyer, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational StudyNeil Powell, Philip Howard, Martin J Llewelyn, et al.
BMJ Open|August 8, 2025
Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sourcesJosie Henley, Lucy Brookes-Howell, Philip Howard, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
Wellcome Open Research|November 16, 2022
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumoniaVilas Navapurkar, Josefin Bartholdson Scott, Mailis Maes, et al.
The Journal of Antimicrobial Chemotherapy|September 9, 2024
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19Jonathan A T Sandoe, Detelina Grozeva, Mahableshwar Albur, et al.
Thorax|October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
JAMA|December 9, 2024
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical TrialPaul Dark, Anower Hossain, Daniel F McAuley, et al.
Annals of Translational Medicine|August 15, 2020
More research is required to understand factors influencing antibiotic prescribing in complex conditions like suspected ventilator-associated pneumoniaThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Pageof 6